Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
Gilead Sciences, Inc.
GILDHealth technology
$148.1B
Market Cap
Shariah Analysis
Passed
Business
Cash
Liabilities
Based on AAOIFI screening standards, Gilead Sciences, Inc. appears to be Passed.
Business Activity
FYE 2024
Non-Permissible Income (<5%)0.00%
Non-Permissible
$6
Total Income
$28.8K
Revenue Breakdown
Product sales
$28.6K
Royalty, contract and other revenues
$144
Other income
Non-Operating
$6
Non-Compliant: $6
Financial Screening
FYE 2024
Cash (<30%)10.33%
Non-Shariah Cash Items
Cash And Cash Equivalents$10B
Other Short Term Investments$1.6B
Liabilities (<30%)23.85%
Non-Shariah Liabilities
Long Term Debt$24.9B
Current Debt$1.8B
Market Data
Exchange
NASDAQ
CurrencyUSD
CountryUnited States
Last Updated2025-12-27
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
NASDAQ
